PO.CH02.02 · 化学

来自pks+ NC101和pks- DH10B大肠杆菌菌株的外膜囊泡(OMVs)的表征

Characterization of outer membrane vesicles (OMVs) from pks+ NC101 and pks- DH10B E. coli strands

海报缩略图:来自pks+ NC101和pks- DH10B大肠杆菌菌株的外膜囊泡(OMVs)的表征
编号 7668 展板 22 时间 4/22 09:00–12:00 区域 Section 38 主讲 Lissette Perez-Rovira, BS
分会场 Multi-Omics, Systems Biology, and Biological Mass Spectrometry
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Lissette Marie Perez-Rovira1, Grace Enid Velez Crespo2, Luis A. Prieto-Costas2, Jeremy J. Colon-Morales2, Abel Baerga-Ortiz2

1University of Puerto Rico Comprehensive Cancer Center, San Juan, PR,2UPR Molecular Science Research Center, San Juan, Puerto Rico

摘要 Abstract

中文摘要
背景与目的:Colibactin是一种由致病性革兰氏阴性细菌中pks基因组岛编码的基因毒素,已被认为与结直肠癌相关。Colibactin的合成和活化分两步进行:先在细菌细胞质中产生前体colibactin(pre-colibactin),随后在周质空间内活化为colibactin。然而,pks⁺细菌将colibactin输出至宿主细胞的机制尚不明确。我们假设外膜囊泡(outer membrane vesicles, OMVs)——由革兰氏阴性细菌释放的、能够运输多种生物分子的纳米级蛋白脂质体——可作为该毒素向宿主细胞递送的系统。 方法:为研究这一问题,我们使用exoEasy Maxi Kit从pks⁺ NC101和pks- DH10B大肠杆菌菌株中分离OMVs,并在Synergy H1酶标仪上用基于BSA的蛋白定量法进行定量。 结果:所得浓度与典型OMV制备物一致。所提取OMVs的稳定性和形态学特征将采用动态光散射(DLS)进行评估。从OMVs中提取的代谢物将通过质谱进行检测,以确认已知colibactin相关中间体的存在。此外,OMVs将接受蛋白质组学分析,以鉴定参与OMV-宿主相互作用机制的蛋白质。最后,我们旨在评估OMV暴露对大肠上皮细胞的影响,以更好地理解其对colibactin相关毒性和结直肠癌发生的作用。 结论:本研究最终旨在阐明OMVs如何介导colibactin的运输和细胞毒性,为促进结直肠癌发生的细菌因素提供新的见解。 致谢:本研究由美国国立过敏和传染病研究所(NIAID)资助,资助号#5R25AI183304-02。
查看英文原文 English abstract
Background & Objectives: Colibactin is a genotoxin encoded by the pks genomic island in pathogenic Gram-negative bacteria and has been implicated in colorectal cancer. Colibactin synthesis and activation occur in a two-step process in which pre-colibactin is produced in the bacterial cytoplasm and subsequently activated into colibactin within the periplasmic space. However, the mechanism by which pks⁺ bacteria export colibactin to host cells remains unclear. We hypothesize that outer membrane vesicles (OMVs), nanosized proteoliposomes released by Gram-negative bacteria capable of transporting diverse biomolecules, serve as a delivery system for this toxin to host cells. Methods: To investigate this, OMVs were isolated from pks⁺ NC101 and pks- DH10B E. coli strains using the exoEasy Maxi Kit and quantified with a BSA-based protein assay on a Synergy H1 microplate reader. Results: Yielding concentrations consistent with typical OMV preparations. The stability and morphological characteristics of the extracted OMVs will be evaluated using dynamic light scattering (DLS). Metabolites extracted from OMVs will be examined via mass spectrometry to confirm the presence of known colibactin-related intermediates. Additionally, OMVs will undergo proteomic analysis to identify proteins involved in OMV-host interaction mechanisms. Finally, we aim to assess the effects of OMV exposure on large intestinal epithelial cells to better understand their contribution to colibactin-associated toxicity and colorectal cancer development. Conclusion: Ultimately, this research seeks to clarify how OMVs mediate colibactin transport and cytotoxicity, providing new insights into bacterial factors that promote colorectal carcinogenesis. Acknowledgements: This research was funded by the National Institute of Allergy and Infectious Diseases (NIAID) Grant #5R25AI183304-02.
利益披露 Disclosure
L. M. Perez-Rovira, None.. G. E. Velez Crespo, None.. L. A. Prieto-Costas, None.. J. J. Colon-Morales, None.. A. Baerga-Ortiz, None.

← 返回 AACR 2026 检索